Challenges of creating and capturing value in open eco-innovation : Evidence from the maritime industry in Denmark

Author's accepted version (post-print).Available from 08/02/2021.Developing eco-innovations using open innovation comes with a distinct set of challenges as the dual goals of economic and environmental value creation produce tension that is not easily overcome in a multi-stakeholder network. These incongruent goals are inherent in an open eco-innovation network and potentially involve governmental agencies, regulators, and non-governmental organizations along with suppliers and other partners. Consequently, they add a layer of complexity to the creation and capture of value throughout the innovation network. Thus, in this study, we ask: What are the challenges in creating and capturing value in open eco-innovation networks? Based on an embedded case study of a network developing eco-innovation over a six-year period in the maritime industry in Denmark, this paper identifies challenges and links them to their impact on value creation and value capture. Our findings indicate that firms and partners are less innovative and more conservative in their approaches to innovation than has previously been observed in open-innovation partnerships. This research contributes to the eco-innovation knowledge base by demonstrating how extracting value from open eco-innovation is complicated as value is created at the micro and meso levels of the network, yet, a major goal of value capture is at the environment and social macro level. Thus, our results indicate that firms are less willing to commit resources and knowledge to co-creation, thereby negatively impacting value capture for the entire network, the society and/or the environment. Using open innovation to address “grand” societal challenges requires understanding value creation and value capture within this micro-meso-macro systemic framework of competing goals.acceptedVersio

Distribution and genetic variability of Staphylinidae across a gradient of anthropogenically influenced insular landscapes

This paper describes the distribution and genetic variability of rove beetles (Coleoptera Staphylinidae) in anthropogenically influenced insular landscapes. The study was conducted in the Azores archipelago, characterized by high anthropogenic influence and landscape fragmentation. Collections were made in five islands, from eight habitats, along a gradient of anthropogenic influence. The species of Staphylinidae from the Azores collected for this study were widely distributed and showed low habitat fidelity. Rove beetle richness was associated with anthropogenic influence and habitat type, increasing from less to more anthropogenic impacted habitats. However, genetic diversity of profiled species (i.e. with three or more specimens per species/habitat) does not seem affected by anthropogenic influence in the different habitat types, isolation or landscape fragmentation. COI haplotypes were, as a rule, not exclusive to a given island or habitat. High level of genetic divergence and nucleotide saturation was found in closely related morphological designated species, demonstrating possible disparities between currently defined taxonomic units based on morphology and molecular phylogenies of Staphylinidae. This study found evidence of cryptic speciation in the Atheta fungi (Gravenhorst) species complex which had thus far remained undetected. Similar trends were found for Oligota parva Kraatz, Oxytelus sculptus Gravenhorst, Oligota pumilio Kiesenwetter. Previous studies with lower taxonomical resolution may have underestimated the biotic diversity reported in the Azores in comparison to other Macaronesian archipelagos.info:eu-repo/semantics/publishedVersio

Consumer Resistance to Green Innovations: Developing a New Scale and an Underlying Framework

The development and marketing of green innovations provide great potential to reduce carbon emissions, ease fossil fuel dependency and stabilize energy costs. The diffusion of many green innovations among consumers, however, remains low and they are often referred to as resistant innovations. Consumer resistance to green innovations is a generally under-researched area and empirical evidence is scarce. The objective of this study is therefore twofold. Building on recent advances in the literature, the study firstly aims to operationalize and empirically validate a measure of consumer resistance to green innovations. Secondly, the research aims to anchor this measure in a theoretically grounded model based around status quo bias theory (Samuelson and Zeckhauser 1988) and empirically test the relative influence of factors leading to consumer resistance to green innovations. The research presented in this study is based on a large scale study of homeowners in the Republic of Ireland. The proposed scale and framework are both empirically validated via structural equation modeling techniques, providing valuable information for marketers and policymakers

High-throughput analysis of the RNA-induced silencing complex in myotonic dystrophy type 1 patients identifies the dysregulation of miR-29c and its target ASB2

Myotonic dystrophy type 1 (DM1) is a multi-systemic disorder caused by abnormally expanded stretches of CTG DNA triplets in the DMPK gene, leading to mutated-transcript RNA-toxicity. MicroRNAs (miRNAs) are short non-coding RNAs that, after maturation, are loaded onto the RISC effector complex that destabilizes target mRNAs and represses their translation. In DM1 muscle biopsies not only the expression, but also the intracellular localization of specific miRNAs is disrupted, leading to the dysregulation of the relevant mRNA targets. To investigate the functional alterations of the miRNA/target interactions in DM1, we analyzed by RNA-sequencing the RISC-associated RNAs in skeletal muscle biopsies derived from DM1 patients and matched controls. The mRNAs found deregulated in DM1 biopsies were involved in pathways and functions relevant for the disease, such as energetic metabolism, calcium signaling, muscle contraction and p53-dependent apoptosis. Bioinformatic analysis of the miRNA/mRNA interactions based on the RISC enrichment profiles, identified 24 miRNA/mRNA correlations. Following validation in 21 independent samples, we focused on the couple miR-29c/ASB2 because of the role of miR-29c in fibrosis (a feature of late-stage DM1 patients) and of ASB2 in the regulation of muscle mass. Luciferase reporter assay confirmed the direct interaction between miR-29c and ASB2. Moreover, decreased miR-29c and increased ASB2 levels were verified also in immortalized myogenic cells and primary fibroblasts, derived from biopsies of DM1 patients and controls. CRISPR/Cas9-mediated deletion of CTG expansions rescued normal miR-29c and ASB2 levels, indicating a direct link between the mutant repeats and the miRNA/target expression. In conclusion, functionally relevant miRNA/mRNA interactions were identified in skeletal muscles of DM1 patients, highlighting the dysfunction of miR-29c and ASB2

A study on otoacoustic emissions and supression effects in patients with vitiligo

Vitiligo is a skin disease characterized by absence of melanin due to melanocytes destruction. AIM: to study the incidence of hearing alterations in patients with vitiligo. METHOD: prospective audiological evaluation, transient-evoked otoacoustic emission recordings and study the effects of suppression in 24 patients with vitiligo. Their ages ranged from 15 to 45 years. RESULTS: 21 patients (87.5%) had normal audiometry; 2 had unilateral hearing loss in the high frequencies and 1 had cochlear moderate hearing loss in the left ear. Of these 21 subjects, 66.7% had no otoacoustic emissions, suggesting cochlear dysfunction. Only 7 patients had otoacoustic emissions present in all frequencies (29.2%) and 17 (70.8%) did not have them, and the highest rate of no otoacoustic emissions happened in the right ear of males. Regarding the suppression study, 6 subjects failed, all of them were females, and their left ears were the most affected. CONCLUSION: the findings show that patients with vitiligo, particularly males, have a greater predisposition to cochlear dysfunction, especially in the right ear. As far as the suppression effect was concerned, there was a greater alteration in the female efferent system, particularly in the left ear. Hearing alterations did not vary as far as age is concerned, type of vitiligo and time of disease progression.Vitiligo é uma doença cutânea, caracterizada pela ausência da melanina, por destruição de melanócitos. OBJETIVO: Verificar a ocorrência de alteração auditiva em indivíduos com vitiligo. MÉTODO: Avaliação audiológica, pesquisa das emissões otoacústicas evocadas transientes e do efeito de supressão em estudo prospectivo de 24 pacientes com vitiligo. A faixa etária variou de 15 a 45 anos. RESULTADOS: 21 pacientes (87.5%) apresentaram audiometria normal; dois apresentaram perda auditiva unilateral em freqüências altas e um apresentou perda coclear de grau moderado à esquerda. Destes 21 sujeitos, 66,7% tiveram ausência de emissões, sugerindo disfunção coclear. As emissões estiveram presentes em todas as bandas de freqüência em apenas 7 pacientes (29,2%) e ausentes em 17 (70,8%), com maior ocorrência de falha no sexo masculino, na orelha direita. Na pesquisa da supressão, seis indivíduos falharam, todos do sexo feminino, sendo a orelha esquerda a mais afetada. CONCLUSÃO: Pela análise das emissões otoacústicas verificou-se que os portadores de vitiligo possuem maior predisposição à disfunção coclear, com maior ocorrência no sexo masculino na orelha direita. Quanto ao efeito de supressão, houve maior alteração no sistema eferente em mulheres, com maior ausência à esquerda. As alterações auditivas não diferiram quanto à idade, tipo de vitiligo e tempo de evolução da doença.Universidade Federal de São Paulo (UNIFESP) Escola Paulista de Medicina Departamento de FonoaudiologiaUniversidade Federal de São Paulo (UNIFESP) Escola Paulista de Medicina Departamento de DermatologiaUniversidade Federal de São Paulo (UNIFESP) Escola Paulista de MedicinaUNIFESP, EPM, Depto. de FonoaudiologiaUNIFESP, EPM, Depto. de DermatologiaUNIFESP, EPMSciEL

Dried blood spots for qPCR diagnosis of acute Bartonella bacilliformis infection.

Bartonella bacilliformis is the etiological agent of a life-threatening illness. Thin blood smear is the most common diagnostic method for acute infection in endemic areas of Peru but remains of limited value because of low sensitivity. The aim of this study was to adapt a B. bacilliformis-specific real-time polymerase chain reaction (PCR) assay for use with dried blood spots (DBS) as a sampling method and assess its performance and use for the diagnosis and surveillance of acute Bartonella infection. Only two of 65 children (3%) that participated in this study had positive blood smears for B. bacilliformis, whereas 16 (including these two) were positive by PCR performed on DBS samples (24.6%). The use of DBS in combination with B. bacilliformis-specific PCR could be a useful tool for public health in identifying and monitoring outbreaks of infection and designing control programs to reduce the burden of this life-threatening illness

Evolució i anàlisi del metabolisme ambiental del polígon industrial. El cas de Maó (Menorca)

El polígon industrial de Maó, POIMA, és un dels principals motors econòmics de l'illa de Menorca. La Universitat Autònoma de Barcelona (UAB) en col·laboració amb l'Observatori Socioambiental de Menorca (OBSAM), ha fet un projecte d'anàlisi de l'evolució històrica i del metabolisme actual del polígon. L'estudi es centra en 5 vectors; usos del sòl, energètic, hídric, materials i mobilitat dels quals les dades han estat obtingudes a partir d'enquestes, entrevistes a les empreses i observacions directes semi-quantitatives. Com a resultat es presenten diverses propostes de millora per augmentar l'eficiència de POIMA, analitzant el potencial d'autosuficiència energètic i hídric, reduint l'impacte ambiental i reutilitzant els residus com a recursos entre empreses, sinèrgies.The Mahon industrial park, POIMA, is the major economic driver of the island of Menorca. The university Autònoma de Barcelona (UAB) cooperating with the Observatori Socioambiental de Menorca (OBSAM) has a draft a project of analysis the history and the current metabolism of POIMA. The study is focused on five vectors, land use, energy, water, materials and mobility the data have been obtained through surveys, interviews to the companies and direct semi-quantitative observations. As a result, some proposal improvements have been designed in order to increase the efficiency of POIMA analyzing the potential of energy and water self-sufficiency, reducing environmental impact and reusing waste as resources between companies, called as a concept synergies

Memory stem T cells modified with a redesigned CD30-chimeric antigen receptor show an enhanced antitumor effect in Hodgkin lymphoma

Altres ajuts: This work was supported in part by grants from La Marató TV3 (Exp. 20130710), Deutsche José Carreras Leukämie Stiftung (DJCSL 10R/2016), Fundación Científica Asociación Española Contra el Cáncer (AECC-AIO2017), Fundacion Bancaria 'La Caixa', TerCel (SG/11/2008)Adoptive cell therapy (ACT) with mature T cells modified with a chimeric antigen receptor has demonstrated improved outcome for B-cell malignancies. However, its application for others such as Hodgkin lymphoma remains a clinical challenge. CD30 antigen, expressed in Hodgkin lymphoma cells, is absent in most healthy tissues, representing an ideal target of ACT for this disease. Despite that, efficacy of CD30-chimeric antigen receptor (CAR) T cells for Hodgkin lymphoma remains modest. Here, we have developed and tested a novel CD30-CAR T to improve efficacy of CD30-CAR therapy, using a targeting epitope within the non-cleavable part of CD30 receptor, and memory stem T cells (T) to improve engraftment, persistence and antitumor activity. T cultures were generated and expanded ex vivo and transduced at day 1 or 2 with a lentiviral vector encoding the CD30-CAR. Therapeutic in vivo experiments were performed using NSG mice injected with L540 (sc) or L428 (iv) and treated with CD30-CAR T cells when the tumor was established. CD30-CAR T cells generated and expanded ex vivo, despite CD30 expression and fratricide killing of CD30 + CAR T cells, were not impaired by soluble CD30 and completely eradicated Hodgkin lymphoma in vivo, showing high persistence and long-lasting immunity. In addition, highly enriched CD30-CAR T products confer a survival advantage in vivo, in contrast to more differentiated CAR T cells, with higher tumor infiltration and enhanced antitumor effect. This study supports the use of a refined CD30-CAR T cells with highly enriched T products to improve clinical efficacy of CAR T for Hodgkin lymphoma. We have studied the efficacy of a redesigned CD30-chimeric antigen receptor (CAR) targeting a proximal epitope to enhance the antitumor efficacy. CD30-CAR T cells show potent in vivo antitumor effect in different Hodgkin lymphoma models, and overcome inhibition by soluble CD30. CD30-CAR memory stem T-cell products show long-term persistence, improved tumor homing and long-lasting immunity

Rapid Syphilis Testing Is Cost-Effective Even in Low-Prevalence Settings: The CISNE-PERU Experience.

Studies have addressed cost-effectiveness of syphilis testing of pregnant women in high-prevalence settings. This study compares costs of rapid syphilis testing (RST) with laboratory-based rapid plasma reagin (RPR) tests in low-prevalence settings in Peru. The RST was introduced in a tertiary-level maternity hospital and in the Ventanilla Network of primary health centers, where syphilis prevalence is approximately 1%. The costs per woman tested and treated with RST at the hospital were $2.70 and$369 respectively compared with $3.60 and$740 for RPR. For the Ventanilla Network the costs per woman tested and treated with RST were $3.19 and$295 respectively compared with $5.55 and$1454 for RPR. The cost per DALY averted using RST was $46 vs.$109 for RPR. RST showed lower costs compared to the WHO standard costs per DALY ($64). Findings suggest syphilis screening with RST is cost-effective in low-prevalence settings